Greetings from the president

July 22nd, 2020
A warm welcome to you for visiting this website.
Samyang Biopharmaceuticals Corp., Inc originated as the pharmaceutical department of Samyang, Inc. and was founded in 2011. It is a pharmaceutical biotechnology company that provides value to 150 customers in 45 countries around the world, mainly through anticancer drugs and sutures.

Based on our future vision: 'Value Generating Pharma Company‘, we have been focusing all our R&D and innovative capabilities on the field of medical biotechnology that is a core area of the 21st century.
To achieve this vision, our Pharmaceutical Business will expand their portfolio of the DDS-based anticancer drug as well as in the biologics-related pharmaceutical field.
Furthermore, the MD division will strengthen the competitiveness of the existing suture business through continuous growth in its global core market and subsequently expand the new portfolio on absorbable materials.
In addition, we completed the construction of Samyang Discovery Center in Pangyo Techno Valley in 2016 and established Samyang Biopharm USA Inc. in 2018. This establishment will serve as a strong foundation for Samyang Biopharmaceuticals Corp. to thrive globally as an innovative R&D-based global pharmaceutical company.

Thank you.

Tae-Ung Eom, President